摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

普萘洛尔杂质 | 77252-87-0

中文名称
普萘洛尔杂质
中文别名
N-[2-羟基-3-(1-萘氧基)丙基]-N-(1-甲基乙基)甲酰胺;N-[2-羟基-3-(1-萘氧基)丙基】-N-(1-甲基乙基)甲酰胺
英文名称
1-<<(1-methylethyl)-formyl>amino>-3-(1-naphthalenyloxy)-2-propanol
英文别名
N-[2-hydroxy-3-(1-naphthalenyloxy)propyl]-N-(1-methylethyl)formamide;(+/-)-N-formylpropranolol;N-formylpropranolol;N-(2-hydroxy-3-(naphthalen-1-yloxy)propyl)-n-isopropylformamide;N-(2-hydroxy-3-naphthalen-1-yloxypropyl)-N-propan-2-ylformamide
普萘洛尔杂质化学式
CAS
77252-87-0
化学式
C17H21NO3
mdl
——
分子量
287.359
InChiKey
HYXSVEOUQCJDND-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    524.6±40.0 °C(Predicted)
  • 密度:
    1.152±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    21
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.35
  • 拓扑面积:
    49.8
  • 氢给体数:
    1
  • 氢受体数:
    3

SDS

SDS:ed107aa34b09a69f1f7b0d20ad7693ab
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    双乙烯酮普萘洛尔杂质4-二甲氨基吡啶 作用下, 以 四氢呋喃 为溶剂, 反应 2.0h, 以55%的产率得到Iyllhqfuqmylay-uhfffaoysa-
    参考文献:
    名称:
    Acetoacetylation with Diketene Catalyzed by 4-Dimethylaminopyridine
    摘要:
    报道了一种有效的方法,将醇1与双酮烯酮2进行乙酰乙酰化反应,生成乙酰乙酸酯3。
    DOI:
    10.1055/s-1989-27260
  • 作为产物:
    描述:
    potassium cyanide普萘洛尔丙二酸二甲酯 作用下, 以 甲醇 为溶剂, 反应 52.0h, 以62%的产率得到普萘洛尔杂质
    参考文献:
    名称:
    新型的N-甲酰化和胺通过氰化物和酯类作为甲酰化剂的相关反应。
    摘要:
    酯促进的氰化物引发了新的N-甲酰化反应和相关的反应。
    DOI:
    10.1039/b810086a
点击查看最新优质反应信息

文献信息

  • Approaches to Mutual Prodrugs: Calcium - β-Blockers
    作者:Abraham Nudelman、Rachel Kelner
    DOI:10.1002/ardp.19933261112
    日期:——
  • Photodegradation products of propranolol: The structures and pharmacological studies
    作者:Koji Uwai、Marie Tani、Yosuke Ohtake、Shinya Abe、Akiko Maruko、Takashi Chiba、Yoshiro Hamaya、Yasuhito Ohkubo、Mitsuhiro Takeshita
    DOI:10.1016/j.lfs.2005.04.033
    日期:2005.12
    Recently, single-dose drug packaging systems, allowing the administration of multiple drugs in a single pill, have become popular for the convenience of the patient. The quality of drugs and an accurate measurement of their photostabilities within this system, however, have not been carefully addressed. Drugs that are unstable in light should be carefully handled to protect their potency and ensure their safety. Propranolol (1), a beta-adrenergic receptor antagonist, is widely used for angina pectoris, arrhythmia, and hypertension. Due to its naphthalene skeleton, this drug may be both light unstable and a photosensitizing agent. In this study, we isolated three photodegraded products of propranolol (1): 1-naphthol (2), N-acetylpropranolol (3), and N-formylpropranolol (4). The structures of these compounds were determined by spectroscopic methods and chemical syntheses. We also examined the acute toxicities of these substances in mice and their binding to beta-adrenergic receptors using rat cerebellum cortex membranes. Although the photoproducts isolated in this study did not exhibit any acute toxicity or significant binding to p-adrenergic receptors, these results serve as a warning to single-dose packaging systems, as propranolol (1) must be handled carefully to protect the compound from light-induced degradation. (c) 2005 Elsevier Inc. All rights reserved.
  • Acetoacetylation with Diketene Catalyzed by 4-Dimethylaminopyridine
    作者:Abraham Nudelman、Rachel Kelner、Neomi Broida、Hugo E. Gottlieb
    DOI:10.1055/s-1989-27260
    日期:——
    A useful procedure for the acetoacetylation of alcohols 1 with diketene 2 to acetoacetic esters 3 is reported.
    报道了一种有效的方法,将醇1与双酮烯酮2进行乙酰乙酰化反应,生成乙酰乙酸酯3。
  • A novel type of N-formylation and related reactions of amines via cyanides and esters as formylating agents
    作者:Kai Bao、Weige Zhang、Xiujuan Bu、Zhichun Song、Liang Zhang、Maosheng Cheng
    DOI:10.1039/b810086a
    日期:——
    A novel N-formylation and related reactions proceed from cyanides promoted by esters.
    酯促进的氰化物引发了新的N-甲酰化反应和相关的反应。
查看更多